ClinicalTrials.gg
Sign In

Reflex Sympathetic Dystrophy clinical trials

The registry lists 43 studies for Reflex Sympathetic Dystrophy across more than 10 countries. 4 are recruiting or about to start. 25 of them are mainly about Reflex Sympathetic Dystrophy (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.

Get an email when these change. Save the Reflex Sympathetic Dystrophy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
24
Status unknown
6
Terminated
6
Recruiting
4
Withdrawn
3

Phase

Phase 3
10
Phase 2
9
Phase 4
2
Phase 1
1

Where

United States
15
Germany
6
Canada
6
France
4
United Kingdom
3
Netherlands
3

Who runs them

Grünenthal GmbH (3) · Ruhr University of Bochum (3) · National Institute of Nursing Research (NINR) (2) · Celgene Corporation (2) · Ambros Therapeutics, Inc. (2) · Green International University (1) · National Taiwan University Hospital (1) · University of California, Davis (1)

What is being tested here

Drugs under test in Reflex Sympathetic Dystrophy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Neridronic acid144
Lenalidomide002
Cannabis sativa subsp. indica TOP001
Diclofenac001
Neurotropin001
Ethosuximide001
Zoledronic Acid011
Immunoglobulins, Intravenous011
Immunoglobulin G011

Coming up

1phase 3 study under way
0studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

Who these studies take

Of the 4 Reflex Sympathetic Dystrophy studies recruiting now, 3 (75%) set no upper age limit and 1 (25%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 4
AgeWomenMen
100 (0%)0 (0%)
183 (75%)3 (75%)
303 (75%)3 (75%)
403 (75%)3 (75%)
504 (100%)4 (100%)
654 (100%)4 (100%)
754 (100%)4 (100%)
853 (75%)3 (75%)

Across all 43 studies, recruiting or not: 30% stop at 75 or younger and 12% at 65; 5% take children; 0% are for women only and 0% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Reflex Sympathetic Dystrophy studies take

Of 15 interventional studies with no phase under Reflex Sympathetic Dystrophy, half reached primary completion within 17 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase17 mo8–47 · 15 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 43 of 43. search them.